Cisplatin is commonly used as a chemotherapeutic drug in the treatment of many solid tumours, including bladder, ovarian, and esophageal tumours. However, when it is metabolised by an enzyme called "cysteine conjugate beta-lyase 1 (CCBL1)," it is transformed to "thiol-cisplatin," a highly ac
Mumbai (Maharashtra) [India], May 23 (ANI/BusinessWire India): As part of Neuropathy Awareness Week 2023, P&G Health brought together globally renowned health experts with 6000 Healthcare Professionals from across Asia, India, Middle East, and Africa at the 'Demystifying Neuropathy Forum
Mumbai (Maharashtra) [India], May 23 (ANI/BusinessWire India): Rakuten Medical, Inc. (Rakuten Medical), a global biotechnology company developing and commercializing precision, cell-targeting therapies based on its proprietary Alluminox™ platform, today announced that the Company has b
Doctors are one step closer to establishing a risk biomarker that will warn them as to which of their paediatric stem cell transplant patients are likely to encounter sinusoidal obstruction syndrome (SOS), a potentially fatal side effect.
Researchers have recorded pain-related data from inside the brains of people suffering from chronic pain issues caused by stroke or amputation (phantom limb pain) for the first time. Understanding how pain is represented by brain activity and how to modify that activity to treat chronic pain
Sepsis is a global health problem, impacting 55 million patients and killing 11 million people each year. Sepsis treatment may include early detection, source management, antibiotics, fluids, vasopressors, and adjuvant therapy. For more than 50 years, corticosteroids have been studied as an
New Delhi [India], May 22 (ANI/SRV): Atyadri Rehaklinik and Hospital, India's first fully integrated transition care hospital, is proud to announce that it has completed care for more than 200 transition care patients since its opening and has achieved an impressive 200 per cent year-over-ye
According to findings presented at Heart Failure 2023, a scientific congress of the European Society of Cardiology (ESC), people with powerful legs are less likely to develop heart failure following a heart attack.
The first investigator-initiated trial of remote pulmonary artery pressure monitoring discovered that it improves the quality of life and decreases heart failure hospitalisations in chronic heart failure patients.
Next-generation DNA sequencing (NGS) methods reveal the presence of bacterial DNA in surgical specimens of hip and knee arthritis from patients having first-time total joint arthroplasty.